Abstract
Since first cases of AIDS up to now, remarkable advances in HIV/AIDS treatment have been achieved. Although a effectiveness vaccine has not yet been developed, the highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of the patients. HIV-1 protease is a valuable drug target, as inhibition of PR activity results in immature noninfectious virions. The major c…